(NASDAQ: SCYX) Scynexis's forecast annual revenue growth rate of -0.21% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 132.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Scynexis's revenue in 2025 is $2,932,000.On average, 5 Wall Street analysts forecast SCYX's revenue for 2025 to be $420,867,567, with the lowest SCYX revenue forecast at $66,682,477, and the highest SCYX revenue forecast at $1,156,892,719. On average, 5 Wall Street analysts forecast SCYX's revenue for 2026 to be $1,644,652,588, with the lowest SCYX revenue forecast at $50,442,000, and the highest SCYX revenue forecast at $3,331,983,640.
In 2027, SCYX is forecast to generate $122,286,179 in revenue, with the lowest revenue forecast at $80,321,121 and the highest revenue forecast at $165,720,014.